Newsbenzinga
Agomab Therapeutics To Present Open-Label Extension Data For Ontunisertib In Fibrostenosing Crohn's Disease At UEG Week On October 20
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…